Shares of Pharma-Bio Serv Inc. (OTCMKTS:PBSV – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.52 and traded as high as $0.5254. Pharma-Bio Serv shares last traded at $0.5254, with a volume of 1,025 shares.
Pharma-Bio Serv Stock Down 7.0%
The stock has a market cap of $12.03 million, a PE ratio of -52.54 and a beta of 0.64. The business’s fifty day moving average is $0.52 and its 200 day moving average is $0.54.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last announced its earnings results on Tuesday, March 17th. The company reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $1.41. Pharma-Bio Serv had a negative net margin of 0.86% and a negative return on equity of 0.66%. The company had revenue of $2.30 million during the quarter, compared to analysts’ expectations of $2.70 million. As a group, analysts predict that Pharma-Bio Serv Inc. will post 0.09 EPS for the current year.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.
See Also
- Five stocks we like better than Pharma-Bio Serv
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.
